{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T04:04:19Z","timestamp":1789877059957,"version":"4.0.1"},"reference-count":125,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003347","name":"Fudan University","doi-asserted-by":"publisher","award":["2023WYRH07"],"award-info":[{"award-number":["2023WYRH07"]}],"id":[{"id":"10.13039\/501100003347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Shanghai City Science and Technology Commission","doi-asserted-by":"publisher","award":["23S11901500"],"award-info":[{"award-number":["23S11901500"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Shanghai City Science and Technology Commission","doi-asserted-by":"publisher","award":["23ZR1413100"],"award-info":[{"award-number":["23ZR1413100"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.apsb.2025.12.008","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T07:56:24Z","timestamp":1765180584000},"page":"2043-2067","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Recent advances in biomedical applications of lyotropic liquid crystals"],"prefix":"10.1016","volume":"16","author":[{"given":"Guojin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanmei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3433-6755","authenticated-orcid":false,"given":"Qing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongjian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2105-107X","authenticated-orcid":false,"given":"Nadia M.","family":"Hamdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8888-1102","authenticated-orcid":false,"given":"Amr","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8369-3006","authenticated-orcid":false,"given":"Gang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9655-7510","authenticated-orcid":false,"given":"Yi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2025.12.008_bib1","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1080\/0267829031000097457","article-title":"Liquid crystals in biology I. Historical, biological and medical aspects","volume":"30","author":"Stewart","year":"2003","journal-title":"Liq Cryst"},{"key":"10.1016\/j.apsb.2025.12.008_bib2","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/070622a0","article-title":"Fl\u00fcssige kristalle: sowie plastizit\u00e4t von kristallen im allgemeinen, molekulare umlagerungen und aggregatzustand\u00e4nderungen","volume":"70","author":"Lehmann","year":"1904","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2025.12.008_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15421407308083312","article-title":"History of liquid crystals","volume":"21","author":"Kelker","year":"1973","journal-title":"Mol Cryst Liq Cryst"},{"key":"10.1016\/j.apsb.2025.12.008_bib4","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1039\/f29767201525","article-title":"Theory of self-assembly of hydrocarbon amphiphiles into micelles and bilayers","volume":"72","author":"Israelachvili","year":"1976","journal-title":"J Chem Soc, Faraday Trans 2"},{"key":"10.1016\/j.apsb.2025.12.008_bib5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0009-3084(80)90026-2","article-title":"Structural relationships between lamellar, cubic and hexagonal phases in monoglyceride\u2013water systems. Possibility of cubic structures in biological systems","volume":"27","author":"Larsson","year":"1980","journal-title":"Chem Phys Lipids"},{"key":"10.1016\/j.apsb.2025.12.008_bib6","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/02678290410001666066","article-title":"Liquid crystals in biology II. Origins and processes of life","volume":"31","author":"Stewart","year":"2004","journal-title":"Liq Cryst"},{"key":"10.1016\/j.apsb.2025.12.008_bib7","article-title":"Photopolymerisable liquid crystals for additive manufacturing","volume":"55","author":"Hu","year":"2022","journal-title":"Addit Manuf"},{"key":"10.1016\/j.apsb.2025.12.008_bib8","article-title":"Thermotropic liquid crystals in drug delivery: a versatile carrier for controlled release","volume":"200","author":"Nesterkina","year":"2024","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.apsb.2025.12.008_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120353","article-title":"Additives-directed lyotropic liquid crystals architecture: simulations and experiments","volume":"600","author":"Wang","year":"2021","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2025.12.008_bib10","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1039\/C1CS15148G","article-title":"Lyotropic liquid crystal engineering-ordered nanostructured small molecule amphiphile self-assembly materials by design","volume":"41","author":"Fong","year":"2012","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.apsb.2025.12.008_bib11","article-title":"Cubic and hexagonal liquid crystals as drug delivery systems","volume":"2014","author":"Chen","year":"2014","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.apsb.2025.12.008_bib12","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejpb.2007.01.001","article-title":"Effect of HLB of additives on the properties and drug release from the glyceryl monooleate matrices","volume":"67","author":"Shah","year":"2007","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.apsb.2025.12.008_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2020.113771","article-title":"Insights of lyotropic liquid crystals in topical drug delivery for targeting various skin disorders","volume":"315","author":"Rapalli","year":"2020","journal-title":"J Mol Liq"},{"key":"10.1016\/j.apsb.2025.12.008_bib14","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ijpharm.2014.11.072","article-title":"Glycerol monooleate liquid crystalline phases used in drug delivery systems","volume":"478","author":"Milak","year":"2015","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2025.12.008_bib15","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.tifs.2005.12.012","article-title":"Monoglyceride self-assembly structures as delivery vehicles","volume":"17","author":"Sagalowicz","year":"2006","journal-title":"Trends Food Sci Technol"},{"key":"10.1016\/j.apsb.2025.12.008_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2021.116919","article-title":"Lyotropic liquid crystalline nanoparticles: scaffolds for delivery of myriad therapeutics and diagnostics","volume":"338","author":"Waheed","year":"2021","journal-title":"J Mol Liq"},{"key":"10.1016\/j.apsb.2025.12.008_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2022.05.036","article-title":"Recent advances in versatile inverse lyotropic liquid crystals","volume":"348","author":"Shan","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.12.008_bib18","doi-asserted-by":"crossref","first-page":"6178","DOI":"10.1021\/acsnano.8b07961","article-title":"Non-lamellar lyotropic liquid crystalline lipid nanoparticles for the next generation of nanomedicine","volume":"13","author":"Zhai","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2025.12.008_bib19","series-title":"Organic materials as smart nanocarriers for drug delivery","author":"Grumezescu","year":"2018"},{"key":"10.1016\/j.apsb.2025.12.008_bib20","doi-asserted-by":"crossref","DOI":"10.1063\/5.0204909","article-title":"Tailoring lyotropic liquid crystals for skin barrier penetration: exploring composition and structure\u2013function relationships","volume":"11","author":"Priya","year":"2024","journal-title":"Appl Phys Rev"},{"key":"10.1016\/j.apsb.2025.12.008_bib21","doi-asserted-by":"crossref","first-page":"12369","DOI":"10.1021\/acs.langmuir.7b03173","article-title":"Lyotropic liquid-crystalline nanosystems as drug delivery agents for 5-fluorouracil: structure and cytotoxicity","volume":"33","author":"Astolfi","year":"2017","journal-title":"Langmuir"},{"key":"10.1016\/j.apsb.2025.12.008_bib22","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.actbio.2019.09.011","article-title":"Self-assembling in situ gel based on lyotropic liquid crystals containing VEGF for tissue regeneration","volume":"99","author":"Wang","year":"2019","journal-title":"Acta Biomater"},{"key":"10.1016\/j.apsb.2025.12.008_bib23","article-title":"Liquid crystal materials for biomedical applications","volume":"35","author":"Zhang","year":"2023","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2025.12.008_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2023.102867","article-title":"Lipidic lyotropic liquid crystals: insights on biomedical applications","volume":"313","author":"Blanco-Fern\u00e1ndez","year":"2023","journal-title":"Adv Colloid Interface Sci"},{"key":"10.1016\/j.apsb.2025.12.008_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123546","article-title":"Lyotropic liquid crystalline phases: drug delivery and biomedical applications","volume":"647","author":"Chavda","year":"2023","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2025.12.008_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2024.109888","article-title":"Oral delivery of insulin by barbed microneedles actuated by intestinal peristalsis","volume":"35","author":"Yu","year":"2024","journal-title":"Chin Chem Lett"},{"key":"10.1016\/j.apsb.2025.12.008_bib27","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1016\/j.apsb.2021.03.025","article-title":"In vitro and in vivo correlation for lipid-based formulations: current status and future perspectives","volume":"11","author":"Huang","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2025.12.008_bib28","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jconrel.2023.08.024","article-title":"Pancreatic lipase digestion: the forgotten barrier in oral administration of lipid-based delivery systems?.","volume":"362","author":"Zupan\u010di\u010d","year":"2023","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.12.008_bib29","article-title":"\u03b2-Lactoglobulin stabilized lipid nanoparticles enhance oral absorption of insulin by slowing down lipolysis","volume":"35","author":"Li","year":"2024","journal-title":"Chin Chem Lett"},{"key":"10.1016\/j.apsb.2025.12.008_bib30","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.cocis.2019.02.002","article-title":"Supramolecular structures in lipid digestion and implications for functional food delivery","volume":"39","author":"Salentinig","year":"2019","journal-title":"Curr Opin Colloid Interface Sci"},{"key":"10.1016\/j.apsb.2025.12.008_bib31","article-title":"Optimizing bioavailability and antihypertensive activity of carvedilol cubosomes using D-optimal design: comparative analysis of cremophor RH 40 and polyvinyl alcohol as secondary stabilizers","volume":"97","author":"Salem","year":"2024","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.apsb.2025.12.008_bib32","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1016\/j.xphs.2021.02.007","article-title":"Cubosomes as a potential oral drug delivery system for enhancing the hepatoprotective effect of coenzyme Q10","volume":"110","author":"Mohsen","year":"2021","journal-title":"J Pharmaceut Sci"},{"key":"10.1016\/j.apsb.2025.12.008_bib33","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s40005-024-00670-1","article-title":"Lyotropic liquid crystalline nanoparticles for oral delivery: formulation and evaluation of sustained-released cromolyn sodium loaded cubosomes","volume":"54","author":"Dinh","year":"2024","journal-title":"J Pharm Invest"},{"key":"10.1016\/j.apsb.2025.12.008_bib34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40360-024-00731-z","article-title":"Sustain-release lipid\u2013liquid crystal formulations of pexiganan against Helicobacter pylori infection: in vitro evaluation in C57BL\/6 mice","volume":"25","author":"Ghazvini","year":"2024","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.apsb.2025.12.008_bib35","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1007\/s13346-020-00851-z","article-title":"Sustained absorption of delamanid from lipid-based formulations as a path to reduced frequency of administration","volume":"11","author":"Ramirez","year":"2021","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.apsb.2025.12.008_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202404234","article-title":"Lipid nanoparticles: versatile drug delivery vehicles for traversing the blood brain barrier to treat brain cancer","volume":"34","author":"Cai","year":"2024","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.apsb.2025.12.008_bib37","doi-asserted-by":"crossref","first-page":"11078","DOI":"10.1021\/acsami.1c21655","article-title":"Affimer tagged cubosomes: targeting of carcinoembryonic antigen expressing colorectal cancer cells using in vitro and in vivo models","volume":"14","author":"Pramanik","year":"2022","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.apsb.2025.12.008_bib38","doi-asserted-by":"crossref","first-page":"48449","DOI":"10.1021\/acsami.2c14375","article-title":"Pegylation of phosphatidylglycerol\/docosahexaenoic acid hexosomes with d-\u03b1-tocopheryl succinate poly(ethylene glycol)2000 induces morphological transformation into vesicles with prolonged circulation times","volume":"14","author":"Bor","year":"2022","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.apsb.2025.12.008_bib39","doi-asserted-by":"crossref","first-page":"12161","DOI":"10.1021\/acsami.3c14709","article-title":"Angiopep-2-functionalized lipid cubosomes for blood\u2013brain barrier crossing and glioblastoma treatment","volume":"16","author":"Cai","year":"2024","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.apsb.2025.12.008_bib40","doi-asserted-by":"crossref","first-page":"12960","DOI":"10.1021\/acsami.7b19109","article-title":"Anisamide-anchored lyotropic nano-liquid crystalline particles with aie effect: a smart optical beacon for tumor imaging and therapy","volume":"10","author":"Urandur","year":"2018","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.apsb.2025.12.008_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-21715-1","article-title":"Design and function of targeted endocannabinoid nanoparticles","volume":"12","author":"Barrie","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2025.12.008_bib42","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jcis.2024.06.091","article-title":"Cubosomes functionalized with antibodies as a potential strategy for the treatment of HER2-positive breast cancer","volume":"673","author":"Victorelli","year":"2024","journal-title":"J Colloid Interface Sci"},{"key":"10.1016\/j.apsb.2025.12.008_bib43","doi-asserted-by":"crossref","first-page":"9268","DOI":"10.3390\/ijms22179268","article-title":"Lipid cubic mesophases combined with superparamagnetic iron oxide nanoparticles: a hybrid multifunctional platform with tunable magnetic properties for nanomedical applications","volume":"22","author":"Caselli","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2025.12.008_bib44","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jcis.2024.06.227","article-title":"Alignment of lyotropic liquid crystals using magnetic nanoparticles improves ionic transport through built-in peptide ion channels","volume":"674","author":"Torabi","year":"2024","journal-title":"J Colloid Interface Sci"},{"key":"10.1016\/j.apsb.2025.12.008_bib45","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jcis.2020.06.006","article-title":"Hexaarylbiimidazoles (HABI)-functionalized lyotropic liquid crystalline systems as visible light-responsive materials","volume":"579","author":"Jia","year":"2020","journal-title":"J Colloid Interface Sci"},{"key":"10.1016\/j.apsb.2025.12.008_bib46","doi-asserted-by":"crossref","first-page":"16556","DOI":"10.1021\/jacs.1c06244","article-title":"Breaking isolation to form new networks: pH-triggered changes in connectivity inside lipid nanoparticles","volume":"143","author":"Xu","year":"2021","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.apsb.2025.12.008_bib47","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.drudis.2017.09.017","article-title":"Overcoming or circumventing the stratum corneum barrier for efficient transcutaneous immunization","volume":"23","author":"Chen","year":"2018","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.apsb.2025.12.008_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.123856","article-title":"Advancements in transdermal drug delivery: a comprehensive review of physical penetration enhancement techniques","volume":"652","author":"Gaikwad","year":"2024","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2025.12.008_bib49","article-title":"Ionic liquids in transdermal drug delivery system: current applications and future perspectives","volume":"34","author":"Zhang","year":"2023","journal-title":"Chin Chem Lett"},{"key":"10.1016\/j.apsb.2025.12.008_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/anbr.202470061","article-title":"Progress in lipid and inorganic nanocarriers for enhanced skin drug delivery","volume":"4","author":"Albakr","year":"2024","journal-title":"Adv NanoBiomed Res"},{"key":"10.1016\/j.apsb.2025.12.008_bib51","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jcis.2023.11.059","article-title":"Cell interactions with lipid nanoparticles possessing different internal nanostructures: liposomes, bicontinuous cubosomes, hexosomes, and discontinuous micellar cubosomes","volume":"656","author":"Yap","year":"2024","journal-title":"J Colloid Interface Sci"},{"key":"10.1016\/j.apsb.2025.12.008_bib52","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1021\/acsabm.4c00153","article-title":"Liposomes to cubosomes: the evolution of lipidic nanocarriers and their cutting-edge biomedical applications","volume":"7","author":"Attri","year":"2024","journal-title":"ACS Appl Bio Mater"},{"key":"10.1016\/j.apsb.2025.12.008_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2023.109442","article-title":"Natural hydrogel dressings in wound care: design, advances, and perspectives","volume":"35","author":"Liang","year":"2024","journal-title":"Chin Chem Lett"},{"key":"10.1016\/j.apsb.2025.12.008_bib54","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41579-023-00905-2","article-title":"Drug delivery strategies for antibiofilm therapy","volume":"21","author":"Choi","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.apsb.2025.12.008_bib55","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.actbio.2021.11.008","article-title":"Lyotropic liquid crystal-based transcutaneous peptide delivery system: evaluation of skin permeability and potential for transcutaneous vaccination","volume":"138","author":"Kozaka","year":"2022","journal-title":"Acta Biomater"},{"key":"10.1016\/j.apsb.2025.12.008_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122853","article-title":"Lyotropic liquid crystal mesophases as transdermal delivery systems for lipophilic drugs: a comparative study","volume":"636","author":"de Araujo","year":"2023","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2025.12.008_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfa.2023.132538","article-title":"Self-assembled lyotropic liquid crystals gel systems for retinol protection and octyl methoxycinnamate skin delivery","volume":"679","author":"Zan","year":"2023","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"key":"10.1016\/j.apsb.2025.12.008_bib58","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2478\/acph-2024-0014","article-title":"Clinical application of hempseed or flaxseed oil-based lyotropic liquid crystals: evaluation of their impact on skin barrier function","volume":"74","author":"Vitek","year":"2024","journal-title":"Acta Pharm"},{"key":"10.1016\/j.apsb.2025.12.008_bib59","article-title":"Evaluation of preclinical efficacy of apremilast-loaded liquid crystalline nanoparticulate gel in amelioration of atopic dermatitis","volume":"96","author":"Nene","year":"2024","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.apsb.2025.12.008_bib60","article-title":"The dexamethasone acetate cubosomes as a potential transdermal delivery system for treating skin inflammation","volume":"75","author":"Jiang","year":"2022","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.apsb.2025.12.008_bib61","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ejpb.2022.10.015","article-title":"Engineering of QbD driven and ultrasonically shaped lyotropic liquid crystalline nanoparticles for apigenin in the management of skin cancer","volume":"180","author":"Waheed","year":"2022","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.apsb.2025.12.008_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114634","article-title":"Apremilast loaded lyotropic liquid crystalline nanoparticles embedded hydrogel for improved permeation and skin retention: an effective approach for psoriasis treatment","volume":"162","author":"Rapalli","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.apsb.2025.12.008_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120483","article-title":"Tenoxicam loaded hyalcubosomes for osteoarthritis","volume":"601","author":"Elakkad","year":"2021","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2025.12.008_bib64","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s12247-024-09829-7","article-title":"Liquid crystal nanoparticles-based fluocinolone acetonide topical gel for atopic dermatitis: in vitro and in vivo study","volume":"19","author":"Shirke","year":"2024","journal-title":"J Pharm Innov"},{"key":"10.1016\/j.apsb.2025.12.008_bib65","doi-asserted-by":"crossref","first-page":"320","DOI":"10.2174\/0122117385269522231113041029","article-title":"Development and characterization of sulfasalazine cubosomes for potential transdermal drug delivery","volume":"13","author":"Mathew","year":"2025","journal-title":"Pharm Nanotechnol"},{"key":"10.1016\/j.apsb.2025.12.008_bib66","article-title":"Curcumin loaded liquid crystalline nanoparticles for enhanced topical application: design, characterization, ex vivo and dermatokinetic evaluation","volume":"92","author":"Tomar","year":"2024","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.apsb.2025.12.008_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2021.117053","article-title":"Exploring the affluent potential of glyceryl mono oleate\u2013myristol liquid crystal nanoparticles mediated localized topical delivery of tofacitinib: study of systematic QbD, skin deposition and dermal pharmacokinetics assessment","volume":"346","author":"Gorantla","year":"2022","journal-title":"J Mol Liq"},{"key":"10.1016\/j.apsb.2025.12.008_bib68","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jid.2024.03.006","article-title":"Skin barrier in atopic dermatitis","volume":"144","author":"Schmuth","year":"2024","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.apsb.2025.12.008_bib69","doi-asserted-by":"crossref","first-page":"227","DOI":"10.15171\/bi.2017.27","article-title":"Development and evaluation of exemestane-loaded lyotropic liquid crystalline gel formulations","volume":"7","author":"Musa","year":"2017","journal-title":"Bioimpacts"},{"key":"10.1016\/j.apsb.2025.12.008_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2023.113728","article-title":"Hesperidin-loaded cubogel as a novel therapeutic armamentarium for full-thickness wound healing","volume":"234","author":"Rehman","year":"2024","journal-title":"Colloids Surf, B"},{"key":"10.1016\/j.apsb.2025.12.008_bib71","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-44304-2","article-title":"Formulation and evaluation of simvastatin cubosomal nanoparticles for assessing its wound healing effect","volume":"13","author":"Ahmed","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2025.12.008_bib72","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202100531","article-title":"Tobramycin liquid crystal nanoparticles eradicate cystic fibrosis-related pseudomonas aeruginosa biofilms","volume":"17","author":"Thorn","year":"2021","journal-title":"Small"},{"key":"10.1016\/j.apsb.2025.12.008_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2022.102536","article-title":"Liquid crystal nanoparticle platform for increased efficacy of cationic antimicrobials against biofilm infections","volume":"42","author":"Thorn","year":"2022","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"10.1016\/j.apsb.2025.12.008_bib74","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1021\/acsinfecdis.1c00014","article-title":"Protective liquid crystal nanoparticles for targeted delivery of PSlG: a biofilm dispersing enzyme","volume":"7","author":"Thorn","year":"2021","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.apsb.2025.12.008_bib75","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.3390\/pharmaceutics14102124","article-title":"Gallium protoporphyrin liquid crystalline lipid nanoparticles: a third-generation photosensitizer against pseudomonas aeruginosa biofilms","volume":"14","author":"Awad","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.apsb.2025.12.008_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.jphotobiol.2022.112474","article-title":"Liquid crystalline lipid nanoparticle promotes the photodynamic activity of gallium protoporphyrin against S. aureus biofilms","volume":"232","author":"Awad","year":"2022","journal-title":"J Photochem Photobiol, B"},{"key":"10.1016\/j.apsb.2025.12.008_bib77","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jcis.2024.04.186","article-title":"Antibacterial and anti-biofilm activities of antibiotic-free phosphatidylglycerol\/docosahexaenoic acid lamellar and non-lamellar liquid crystalline nanoparticles","volume":"669","author":"Jan","year":"2024","journal-title":"J Colloid Interface Sci"},{"key":"10.1016\/j.apsb.2025.12.008_bib78","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.actbio.2022.05.052","article-title":"Guanidinium-rich lipopeptide functionalized bacteria-absorbing sponge as an effective trap-and-kill system for the elimination of focal bacterial infection","volume":"148","author":"Li","year":"2022","journal-title":"Acta Biomater"},{"key":"10.1016\/j.apsb.2025.12.008_bib79","doi-asserted-by":"crossref","first-page":"8121","DOI":"10.1039\/D1TB01201K","article-title":"A bacteria-resistant and self-healing spray dressing based on lyotropic liquid crystals to treat infected post-operative wounds","volume":"9","author":"Yue","year":"2021","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.apsb.2025.12.008_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123442","article-title":"Guard against internal and external: an antibacterial, anti-inflammation and healing-promoting spray gel based on lyotropic liquid crystals for the treatment of diabetic wound","volume":"646","author":"He","year":"2023","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2025.12.008_bib81","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1208\/s12249-024-02852-4","article-title":"Mucoadhesive chitosan composite sponge as a carrier for \u03b2-sitosterol cubosomes for thermal burn treatment","volume":"25","author":"Khattab","year":"2024","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.apsb.2025.12.008_bib82","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jconrel.2020.10.025","article-title":"Therapeutic nanoemulsions in ophthalmic drug administration: concept in formulations and characterization techniques for ocular drug delivery","volume":"328","author":"Singh","year":"2020","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.12.008_bib83","article-title":"Perspective use of bio-adhesive liquid crystals as ophthalmic drug delivery systems","volume":"13","author":"Tarsitano","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2025.12.008_bib84","article-title":"Limonene-enriched ultra-structural cubosomes to augment ocular delivery of a poorly water soluble anti-fungal drug: fabrication, characterization, statistical optimization, in vivo corneal uptake and histopathological evaluation in rabbits","volume":"98","author":"Nemr","year":"2024","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.apsb.2025.12.008_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.127930","article-title":"Controlled release, chitosan-tethered luteolin phytocubosomes; formulation optimization to in-vivo antiglaucoma and anti-inflammatory ocular evaluation","volume":"254","author":"Omran","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.apsb.2025.12.008_bib86","article-title":"Development and optimization of ocular in situ gels loaded with ciprofloxacin cubic liquid crystalline nanoparticles","volume":"57","author":"Alharbi","year":"2020","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.apsb.2025.12.008_bib87","article-title":"Central composite optimization of ocular mucoadhesive cubosomes for enhanced bioavailability and controlled delivery of voriconazole","volume":"61","author":"Said","year":"2021","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.apsb.2025.12.008_bib88","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1080\/10717544.2021.1965675","article-title":"Nanocubosomal based in situ gel loaded with natamycin for ocular fungal diseases: development, optimization, in-vitro, and in-vivo assessment","volume":"28","author":"Hosny","year":"2021","journal-title":"Drug Deliv"},{"key":"10.1016\/j.apsb.2025.12.008_bib89","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1007\/s13346-021-01072-8","article-title":"Preclinical assessment of nanostructured liquid crystalline particles for the management of bacterial keratitis: in vivo and pharmacokinetics study","volume":"12","author":"Kaul","year":"2022","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.apsb.2025.12.008_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111548","article-title":"QbD-driven formulation development and evaluation of topical hydrogel containing ketoconazole loaded cubosomes","volume":"119","author":"Rapalli","year":"2021","journal-title":"Mater Sci Eng, C"},{"key":"10.1016\/j.apsb.2025.12.008_bib91","doi-asserted-by":"crossref","first-page":"209","DOI":"10.55544\/jrasb.3.3.33","article-title":"Cubosomes; an approach to sustain and improve the ocular delivery for glaucoma treatment: box benhken optimization, formulation, in vitro characterization and ex vivo permeation study","volume":"3","author":"Aher","year":"2024","journal-title":"J Res Appl Sci Biotechnol"},{"key":"10.1016\/j.apsb.2025.12.008_bib92","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bpc.2015.02.001","article-title":"Effects of terpenes on fluidity and lipid extraction in phospholipid membranes","volume":"198","author":"Mendanha","year":"2015","journal-title":"Biophys Chem"},{"key":"10.1016\/j.apsb.2025.12.008_bib93","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1208\/s12249-017-0763-8","article-title":"Ocular cubosome drug delivery system for timolol maleate: preparation, characterization, cytotoxicity, ex vivo, and in vivo evaluation","volume":"18","author":"Huang","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.apsb.2025.12.008_bib94","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ijpharm.2018.10.057","article-title":"Corneal targeted sertaconazole nitrate loaded cubosomes: preparation, statistical optimization, in vitro characterization, ex vivo permeation and in vivo studies","volume":"553","author":"Younes","year":"2018","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2025.12.008_bib95","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ijpharm.2006.12.038","article-title":"Development of a poloxamer analogs\/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin","volume":"337","author":"Qi","year":"2007","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2025.12.008_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115196","article-title":"Intranasal drug delivery: the interaction between nanoparticles and the nose-to-brain pathway","volume":"207","author":"Chen","year":"2024","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2025.12.008_bib97","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s43094-024-00665-7","article-title":"Cubosomes: evolving platform for intranasal drug delivery of neurotherapeutics","volume":"10","author":"Gawarkar Patil","year":"2024","journal-title":"Future J Pharm Sci"},{"key":"10.1016\/j.apsb.2025.12.008_bib98","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1208\/s12249-024-02810-0","article-title":"In-depth mechanism, challenges, and opportunities of delivering therapeutics in brain using intranasal route","volume":"25","author":"Ghosh","year":"2024","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.apsb.2025.12.008_bib99","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1007\/s00210-023-02879-7","article-title":"Cubosomes as versatile lipid nanocarriers for neurological disorder therapeutics: a comprehensive review","volume":"397","author":"S","year":"2024","journal-title":"N-s Arch Pharmacol"},{"key":"10.1016\/j.apsb.2025.12.008_bib100","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1080\/02652048.2023.2209651","article-title":"Intranasal spray of cubosomal tizanidine hydrochloride for brain targeting: in vitro and in vivo characterisation","volume":"40","author":"Thakkar","year":"2023","journal-title":"J Microencapsul"},{"key":"10.1016\/j.apsb.2025.12.008_bib101","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202470093","article-title":"Lipid and transcriptional regulation in a parkinson\u2019s disease mouse model by intranasal vesicular and hexosomal plasmalogen-based nanomedicines","volume":"13","author":"Wu","year":"2024","journal-title":"Adv Healthcare Mater"},{"key":"10.1016\/j.apsb.2025.12.008_bib102","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1021\/acs.molpharmaceut.4c00085","article-title":"Potentiation of brain bioavailability using thermoreversible cubosomal formulation","volume":"21","author":"Jain","year":"2024","journal-title":"Mol Pharm"},{"key":"10.1016\/j.apsb.2025.12.008_bib103","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1208\/s12249-024-02814-w","article-title":"Verapamil-loaded cubosomes for enhancing intranasal drug delivery: development, characterization, ex vivo permeation, and brain biodistribution studies","volume":"25","author":"Faisal","year":"2024","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.apsb.2025.12.008_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.111721","article-title":"The liquid crystalline phase behaviour of a nasal formulation modifies the brain disposition of donepezil in rats in the treatment of alzheimer\u2019s disease","volume":"203","author":"de Souza","year":"2021","journal-title":"Colloids Surf, B"},{"key":"10.1016\/j.apsb.2025.12.008_bib105","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/j.xphs.2020.03.030","article-title":"In situ hexosomal gel as a promising tool to ameliorate the transnasal brain delivery of vinpocetine: central composite optimization and in vivo biodistribution","volume":"109","author":"Bakr","year":"2020","journal-title":"J Pharmaceut Sci"},{"key":"10.1016\/j.apsb.2025.12.008_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.111534","article-title":"Intranasal versus intraperitoneal Myrj 59-stabilized cubosomes: a potential armamentarium of effective anti-diabetic therapy","volume":"199","author":"Mansour","year":"2021","journal-title":"Colloids Surf, B"},{"key":"10.1016\/j.apsb.2025.12.008_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2023.108250","article-title":"PLGA-based implants for sustained delivery of peptides\/proteins: current status, challenge and perspectives","volume":"34","author":"Hu","year":"2023","journal-title":"Chin Chem Lett"},{"key":"10.1016\/j.apsb.2025.12.008_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114901","article-title":"Recent advances in lipid-based long-acting injectable depot formulations","volume":"199","author":"Sharma","year":"2023","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2025.12.008_bib109","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1080\/17425247.2022.2106213","article-title":"Smart design of patient-centric long-acting products: from preclinical to marketed pipeline trends and opportunities","volume":"19","author":"Bassand","year":"2022","journal-title":"Expet Opin Drug Deliv"},{"key":"10.1016\/j.apsb.2025.12.008_bib110","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41578-021-00405-w","article-title":"Clinical translation of long-acting drug delivery formulations","volume":"7","author":"Li","year":"2022","journal-title":"Nat Rev Mater"},{"key":"10.1016\/j.apsb.2025.12.008_bib111","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1016\/j.apsb.2021.05.002","article-title":"A review of existing strategies for designing long-acting parenteral formulations: focus on underlying mechanisms, and future perspectives","volume":"11","author":"Shi","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2025.12.008_bib112","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.addr.2020.11.008","article-title":"Clinically established biodegradable long acting injectables: an industry perspective","volume":"167","author":"Nkanga","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2025.12.008_bib113","doi-asserted-by":"crossref","first-page":"9688","DOI":"10.1021\/acsnano.4c01206","article-title":"A long-acting lyotropic liquid crystalline implant promotes the drainage of macromolecules by brain-related lymphatic system in treating aged alzheimer\u2019s disease","volume":"18","author":"Shan","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2025.12.008_bib114","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1007\/s13346-023-01449-x","article-title":"A liquid crystal in situ gel based on rotigotine for the treatment of parkinson\u2019s disease","volume":"14","author":"Wu","year":"2024","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.apsb.2025.12.008_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122947","article-title":"Prolonged local delivery of doxorubicin to cancer cells using lipid liquid crystalline system","volume":"639","author":"Karimi","year":"2023","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2025.12.008_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121275","article-title":"Comparison of lipid liquid crystal formulation and vivitrol\u00ae for sustained release of naltrexone: in vitro evaluation and pharmacokinetics in rats","volume":"611","author":"Kamali","year":"2022","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2025.12.008_bib117","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/j.xphs.2023.04.010","article-title":"A novel molecular reservoir based on reverse self-assembled liquid crystals\u2014a new strategy for prolonging the duration in action of analgesics","volume":"112","author":"Cao","year":"2023","journal-title":"J Pharmaceut Sci"},{"key":"10.1016\/j.apsb.2025.12.008_bib118","article-title":"A sustain-release lipid\u2013liquid crystal containing risperidone based on glycerol monooleate, glycerol dioleate, and glycerol trioleate: in-vitro evaluation and pharmacokinetics in rabbits","volume":"70","author":"Shiadeh","year":"2022","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.apsb.2025.12.008_bib119","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1021\/acs.molpharmaceut.1c00782","article-title":"An injectable in situ depot-forming lipidic lyotropic liquid crystal system for localized intratumoral drug delivery","volume":"19","author":"Saklani","year":"2022","journal-title":"Mol Pharm"},{"key":"10.1016\/j.apsb.2025.12.008_bib120","doi-asserted-by":"crossref","first-page":"29098","DOI":"10.1021\/acsami.4c01432","article-title":"Synchronized codelivery of combination chemotherapies intratumorally using a lipidic lyotropic liquid crystal system","volume":"16","author":"Saklani","year":"2024","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.apsb.2025.12.008_bib121","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jconrel.2021.08.062","article-title":"In situ biomimetic lyotropic liquid crystal gel for full-thickness cartilage defect regeneration","volume":"338","author":"Wang","year":"2021","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.12.008_bib122","doi-asserted-by":"crossref","first-page":"7205","DOI":"10.1039\/D1BM00727K","article-title":"Self-assembled lyotropic liquid crystal gel for osteoarthritis treatment via anti-inflammation and cartilage protection","volume":"9","author":"Mei","year":"2021","journal-title":"Biomater Sci"},{"key":"10.1016\/j.apsb.2025.12.008_bib123","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.3390\/molecules23092275","article-title":"Development and evaluation of minocycline hydrochloride-loaded in situ cubic liquid crystal for intra-periodontal pocket administration","volume":"23","author":"Yang","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.apsb.2025.12.008_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106762","article-title":"Cubic liquid crystals containing propolis flavonoids as in situ thermo-sensitive hydrogel depots for periodontitis treatment: preparation, pharmacodynamics and therapeutic mechanisms","volume":"196","author":"Tang","year":"2024","journal-title":"Eur J Pharmaceut Sci"},{"key":"10.1016\/j.apsb.2025.12.008_bib125","article-title":"Preparation and characterization of injectable in-situ forming gel based on lipid liquid crystal for one month delivery of aripiprazole: in-vitro and in-vivo evaluations in rats","volume":"96","author":"Karimi","year":"2024","journal-title":"J Drug Deliv Sci Technol"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383525007993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383525007993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T19:33:16Z","timestamp":1779823996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383525007993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":125,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2211383525007993"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2025.12.008","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in biomedical applications of lyotropic liquid crystals","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2025.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}